根据 Gen Consulting 公司发布的市场研究报告, the market size of the global biological safety testing sector is expected to rise by USD 14 亿，复合年增长率为 16.3% 到年底 2028.

该行业报告提供了全球市场的市场预测, followed by a detailed analysis of the segmentation, 技术, 应用, 和地区. The global market data on biological safety testing can be segmented by segmentation: analytical testing, in vitro testing, in vivo testing. The analytical testing segment captured the largest share of the market in 2021. Biological safety testing market is further segmented by technology: animal–based, cell–based, in vitro kits, protein (mAb), 其他的. The mAb segment held the largest share of the global biological safety testing market in 2021 预计在预测期内将持有其份额. 根据应用, the biological safety testing market is segmented into: adventitious agents, host cell contaminant testing, product release testing, pyrogen and endotoxins testing, sterility and bioburden testing. 在 2021, the product release testing segment made up the largest share of revenue generated by the biological safety testing market. 根据地区, the biological safety testing market also can be divided into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

The global biological safety testing market is highly competitive. The prominent players operating in the global biological safety testing market include BioReliance Corporation, Charles River Laboratories Inc., Eurofins Scientific SE, 龙沙集团公司, SGS S.A., 赛默飞世尔科技公司, WuXi AppTec Co. 有限公司.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
– Get a detailed picture of the Global Biological Safety Testing Market
– Identify segments/areas to invest in over the forecast period in the Global Biological Safety Testing Market
– 了解竞争环境, 市场的领先参与者
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.